Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Groupe Français de Pneumo-Oncologie

France 84 avenue de la République, 63050 Clermont Ferrand, France

About the sponsor

The clinical research activity centers on non-small-cell lung cancer, with a particular focus on advanced disease in the thoracic setting. The sponsor’s funded trial work is directed toward patients with stage III/IV NSCLC, reflecting a clear interest in lung cancer care.

  • Advanced NSCLC
  • Thoracic malignancies
  • Lung cancer treatment

This area is closely tied to the management of difficult-to-treat lung cancer populations seen in specialist oncology practice.

About Specializations

Groupe Français de Pneumo-Oncologie runs clinical trials in conditions such as Non-small cell lung cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Non-small cell lung cancer

Recruiting

Study of Repotrectinib for Frail or Elderly Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Rearrangement

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Repotrectinib
  • Sponsor:Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.